Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 12

International Journal of Chronic Obstructive Pulmonary Disease


Archive: Volume 12, 2017

Computerized screening for cognitive impairment in patients with COPD

Campman C, van Ranst D, Meijer JW, Sitskoorn M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3075-3083

Published Date: 19 October 2017

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD

Janson C, Stratelis G, Miller-Larsson A, Harrison TW, Larsson K

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3055-3064

Published Date: 19 October 2017

High prevalence of COPD in atherosclerosis patients

Tuleta I, Farrag T, Busse L, Pizarro C, Schaefer C, Pingel S, Nickenig G, Skowasch D, Schahab N

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3047-3053

Published Date: 19 October 2017

Beta-blocker under-use in COPD patients

Lim KP, Loughrey S, Musk M, Lavender M, Wrobel JP

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3041-3046

Published Date: 17 October 2017

Characteristics and potential role of M2 macrophages in COPD

He S, Xie L, Lu J, Sun S

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3029-3039

Published Date: 17 October 2017

Mesenchymal stromal cell therapy in COPD: from bench to bedside

Antunes MA, Lapa e Silva JR, Rocco PRM

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3017-3027

Published Date: 16 October 2017

Echo intensity of the rectus femoris in stable COPD patients

Ye X, Wang MJ, Xiao H

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3007-3015

Published Date: 13 October 2017

Entropy change of biological dynamics in COPD

Jin Y, Chen C, Cao Z, Sun B, Lo IL, Liu T, Zheng J, Sun S, Shi Y, Zhang XD

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2997-3005

Published Date: 12 October 2017

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD

Huang YL, Lai CC, Wang YH, Wang CY, Wang JY, Wang HC, Yu CJ, Chen LW

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2987-2996

Published Date: 11 October 2017

Acute exacerbated COPD: room for improvement in key elements of care

Markun S, Franzen DP, Dalla Lana K, Beyer S, Wieser S, Hess T, Kohler M, Rosemann T, Senn O, Steurer-Stey C

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2969-2975

Published Date: 10 October 2017

Positive end-expiratory pressure attenuates hemodynamic effects induced by an overload of inspiratory muscles in patients with COPD

Schaper-Magalhães F, Pinho JF, Capuruço CAB, Rodrigues-Machado MG

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2943-2954

Published Date: 6 October 2017

Effectiveness of treatment with nebulized colistin in patients with COPD

Bruguera-Avila N, Marín A, Garcia-Olive I, Radua J, Prat C, Gil M, Ruiz-Manzano J

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2909-2915

Published Date: 5 October 2017

Impact and prevention of severe exacerbations of COPD: a review of the evidence

Halpin DMG, Miravitlles M, Metzdorf N, Celli B

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2891-2908

Published Date: 5 October 2017

Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East–North Africa region, 2017

Mahboub BH, Vats MG, Al Zaabi A, Iqbal MN, Safwat T, Al-Hurish F, Miravitlles M, Singh D, Asad K, Zeineldine S, Al-Hajjaj MS

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2869-2890

Published Date: 9 October 2017

Use of the forced-oscillation technique to estimate spirometry values

Yamamoto S, Miyoshi S, Katayama H, Okazaki M, Shigematsu H, Sano Y, Matsubara M, Hamaguchi N, Okura T, Higaki J

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2859-2868

Published Date: 3 October 2017

Risk of cancer after lung transplantation for COPD

Ekström M, Riise GC, Tanash HA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2841-2847

Published Date: 3 October 2017

The association between objectively measured physical activity and morning symptoms in COPD

van Buul AR, Kasteleyn MJ, Chavannes NH, Taube C

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2831-2840

Published Date: 3 October 2017

Associations between the psychological health of patients and carers in advanced COPD

Mi E, Mi E, Ewing G, Mahadeva R, Gardener AC, Holt Butcher H, Booth S, Farquhar M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2813-2821

Published Date: 30 September 2017

Specific IgA against Pseudomonas aeruginosa in severe COPD

Millares L, Martí S, Ardanuy C, Liñares J, Santos S, Dorca J, García-Nuñez M, Quero S, Monsó E

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2807-2811

Published Date: 30 September 2017

Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial

Duenk RG, Verhagen C, Bronkhorst EM, van Mierlo PJWB, Broeders MEAC, Collard SM, Dekhuijzen PNR, Vissers KCP, Heijdra Y, Engels Y

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2795-2806

Published Date: 28 September 2017

Systemic effects of chronic obstructive pulmonary disease in young-old adults’ life-space mobility

Garcia IFF, Tiuganji CT, Simões MSMP, Santoro IL, Lunardi AC

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2777-2785

Published Date: 27 September 2017

Community pharmacy-based case finding for COPD in urban and rural settings is feasible and effective

Fathima M, Saini B, Foster JM, Armour CL

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2753-2761

Published Date: 18 September 2017

Self-management behaviors to reduce exacerbation impact in COPD patients: a Delphi study

Korpershoek YJG, Bruins Slot JC, Effing TW, Schuurmans MJ, Trappenburg JCA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2735-2746

Published Date: 15 September 2017

Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function

Lim JU, Kim K, Kim SH, Lee MG, Lee SY, Yoo KH, Lee SH, Jung KS, Rhee CK, Hwang YI

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2711-2721

Published Date: 11 September 2017

Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap

Gao J, Zhou WT, Chen BD, Lin WM, Wu SF, Wu F

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2703-2710

Published Date: 11 September 2017

Acute exacerbations of COPD: risk factors for failure and relapse

Mantero M, Rogliani P, Di Pasquale M, Polverino E, Crisafulli E, Guerrero M, Gramegna A, Cazzola M, Blasi F

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2687-2693

Published Date: 8 September 2017

The use of the practice walk test in pulmonary rehabilitation program: National COPD Audit Pulmonary Rehabilitation Workstream

Hakamy A, McKeever TM, Steiner MC, Roberts CM, Singh SJ, Bolton CE

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2681-2686

Published Date: 8 September 2017

Usefulness of the desaturation–distance ratio from the six-minute walk test for patients with COPD

Fujimoto Y, Oki Y, Kaneko M, Sakai H, Misu S, Yamaguchi T, Mitani Y, Yasuda H, Ishikawa A

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2669-2675

Published Date: 6 September 2017

Capillary PO2 does not adequately reflect arterial PO2 in hypoxemic COPD patients

Magnet FS, Majorski DS, Callegari J, Schwarz SB, Schmoor C, Windisch W, Storre JH

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2647-2653

Published Date: 6 September 2017

Differences in systemic inflammation between cigarette and biomass smoke-induced COPD

Golpe R, Martín-Robles I, Sanjuán-López P, Pérez-de-Llano L, González-Juanatey C, López-Campos JL, Arellano-Orden E

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2639-2646

Published Date: 1 September 2017

Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD

Everaerts S, Lagrou K, Dubbeldam A, Lorent N, Vermeersch K, Van Hoeyveld E, Bossuyt X, Dupont LJ, Vanaudenaerde BM, Janssens W

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2629-2638

Published Date: 31 August 2017

A new functional method to choose the target lobe for lung volume reduction in emphysema – comparison with the conventional densitometric method

Hetzel J, Boeckeler M, Horger M, Ehab A, Kloth C, Wagner R, Freitag L, Slebos DJ, Lewis RA, Haentschel M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2621-2628

Published Date: 30 August 2017

Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research – a consensus document from six scientific societies

Rossi A, Butorac-Petanjek B, Chilosi M, Cosío BG, Flezar M, Koulouris N, Marin J, Miculinic N, Polese G, Samaržija M, Skrgat S, Vassilakopoulos T, Vukić-Dugac A, Zakynthinos S, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2593-2610

Published Date: 29 August 2017

Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: a pilot trial

Rafiq R, Prins HJ, Boersma WG, Daniels JMA, den Heijer M, Lips P, de Jongh RT

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2583-2592

Published Date: 28 August 2017

Comparison of pulsed versus continuous oxygen delivery using realistic adult nasal airway replicas

Chen JZ, Katz IM, Pichelin M, Zhu K, Caillibotte G, Noga ML, Finlay WH, Martin AR

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2559-2571

Published Date: 24 August 2017

ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD

Watz H, Troosters T, Beeh KM, Garcia-Aymerich J, Paggiaro P, Molins E, Notari M, Zapata A, Jarreta D, Garcia Gil E

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2545-2558

Published Date: 24 August 2017

Determinants of each domain of the Short Physical Performance Battery in COPD

Bernabeu-Mora R, Giménez-Giménez LM, Montilla-Herrador J, García-Guillamón G, García-Vidal JA, Medina-Mirapeix F

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2539-2544

Published Date: 23 August 2017

Effect of a rehabilitation-based chronic disease management program targeting severe COPD exacerbations on readmission patterns

Lalmolda C, Coll-Fernández R, Martínez N, Baré M, Teixidó Colet M, Epelde F, Monso E

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2531-2538

Published Date: 23 August 2017

Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients

Lim JU, Lee JH, Kim JS, Hwang YI, Kim T, Lim SY, Yoo KH, Jung KS, Kim YK, Rhee CK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2465-2475

Published Date: 21 August 2017

Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD

Song JH, Lee C, Kim JW, Lee WY, Jung JY, Park JH, Jung KS, Yoo KH, Park YB, Kim DK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2455-2464

Published Date: 17 August 2017

Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom

Braeken DCW, Rohde GGU, Franssen FME, Driessen JHM, van Staa TP, Souverein PC, Wouters EFM, de Vries F

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2425-2432

Published Date: 14 August 2017

Overdiagnosis of COPD in hospitalized patients

Spero K, Bayasi G, Beaudry L, Barber KR, Khorfan F

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2417-2423

Published Date: 11 August 2017

Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease

Majewski S, Pietrzak A, Tworek D, Szewczyk K, Kumor-Kisielewska A, Kurmanowska Z, Górski P, Zalewska-Janowska A, Piotrowski WJ

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2407-2415

Published Date: 11 August 2017

Hand grip strength in patients with chronic obstructive pulmonary disease

Jeong M, Kang HK, Song P, Park HK, Jung H, Lee SS, Koo HK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2385-2390

Published Date: 9 August 2017

A comprehensive analysis of association of medical history with airflow limitation: a cross-sectional study

Nishida Y, Takahashi Y, Tezuka K, Yamazaki K, Yada Y, Nakayama T, Asai S

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2363-2371

Published Date: 8 August 2017

Small airways disease: time for a revisit?

Stockley JA, Cooper BG, Stockley RA, Sapey E

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2343-2353

Published Date: 7 August 2017

Hand grip strength and chronic obstructive pulmonary disease in Korea: an analysis in KNHANES VI

Lee SH, Kim SJ, Han Y, Ryu YJ, Lee JH, Chang JH

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2313-2321

Published Date: 4 August 2017

When is dual bronchodilation indicated in COPD?

Thomas M, Halpin DMG, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2291-2305

Published Date: 3 August 2017

Platelet distribution width as a prognostic factor in patients with COPD – pilot study

Białas AJ, Pedone C, Piotrowski WJ, Antonelli Incalzi R

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2261-2267

Published Date: 1 August 2017

Improving adherence to alpha-1 antitrypsin deficiency screening guidelines using the pulmonary function laboratory

Luna Diaz LV, Iupe I, Zavala B, Balestrini KC, Guerrero A, Holt G, Calderon-Candelario R, Mirsaeidi M, Campos M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2257-2259

Published Date: 31 July 2017

Prognostic variables and scores identifying the end of life in COPD: a systematic review

Smith LE, Moore E, Ali I, Smeeth L, Stone P, Quint JK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2239-2256

Published Date: 31 July 2017

Increased parasympathetic cardiac modulation in patients with acute exacerbation of COPD: how should we interpret it?

Kabbach EZ, Mazzuco A, Borghi-Silva A, Cabiddu R, Agnoleto AG, Barbosa JF, de Carvalho Junior LCS, Mendes RG

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2221-2230

Published Date: 28 July 2017

Tiotropium bromide exerts anti-inflammatory effects during resistive breathing, an experimental model of severe airway obstruction

Toumpanakis D, Loverdos K, Tzouda V, Vassilakopoulou V, Litsiou E, Magkou C, Karavana V, Pieper M, Vassilakopoulos T

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2207-2220

Published Date: 28 July 2017

Pathophysiological mechanism of long-term noninvasive ventilation in stable hypercapnic patients with COPD using functional respiratory imaging

Hajian B, De Backer J, Sneyers C, Ferreira F, Barboza KC, Leemans G, Vos W, De Backer W

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2197-2205

Published Date: 28 July 2017

Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study

Celli B, Blasi F, Gaga M, Singh D, Vogelmeier C, Pegoraro V, Caputo N, Agusti A

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2189-2196

Published Date: 27 July 2017

The association of tidal EFL with exercise performance, exacerbations, and death in COPD

Aarli BB, Calverley PM, Jensen RL, Dellacà R, Eagan TM, Bakke PS, Hardie JA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2179-2188

Published Date: 26 July 2017

Counseling for health behavior change in people with COPD: systematic review

Williams MT, Effing TW, Paquet C, Gibbs CA, Lewthwaite H, Li LSK, Phillips AC, Johnston KN

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2165-2178

Published Date: 26 July 2017

Spreading improvements for advanced COPD care through a Canadian Collaborative

Rocker GM, Amar C, Laframboise WL, Burns J, Verma JY

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2157-2164

Published Date: 26 July 2017

Emerging pharmaceutical therapies for COPD

Lakshmi SP, Reddy AT, Reddy RC

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2141-2156

Published Date: 21 July 2017

Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care

Duenk RG, Verhagen C, Bronkhorst EM, Djamin RS, Bosman GJ, Lammers E, Dekhuijzen PNR, Vissers KCP, Engels Y, Heijdra Y

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2121-2128

Published Date: 20 July 2017

Bacteriological incidence in pneumonia patients with pulmonary emphysema: a bacterial floral analysis using the 16S ribosomal RNA gene in bronchoalveolar lavage fluid

Naito K, Yamasaki K, Yatera K, Akata K, Noguchi S, Kawanami T, Fukuda K, Kido T, Ishimoto H, Mukae H

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2111-2120

Published Date: 20 July 2017

COPD patients’ self-reported adherence, psychosocial factors and mild cognitive impairment in pulmonary rehabilitation

Pierobon A, Sini Bottelli E, Ranzini L, Bruschi C, Maestri R, Bertolotti G, Sommaruga M, Torlaschi V, Callegari S, Giardini A

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2059-2067

Published Date: 18 July 2017

Voluntary lung function screening to reveal new COPD cases in southern Italy

Capozzolo A, Castellana G, Dragonieri S, Carratù P, Liotino V, Vulpi MR, Marra L, Resta E, Intiglietta P, Resta O

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2035-2042

Published Date: 11 July 2017

Alteration of the irisin–brain-derived neurotrophic factor axis contributes to disturbance of mood in COPD patients

Papp C, Pak K, Erdei T, Juhasz B, Seres I, Szentpéteri A, Kardos L, Szilasi M, Gesztelyi R, Zsuga J

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2023-2033

Published Date: 7 July 2017

Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers

Caram LMO, Ferrari R, Nogueira DL, Oliveira MRM, Francisqueti FV, Tanni SE, Corrêa CR, Godoy I

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2015-2021

Published Date: 7 July 2017

Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study

Singh D, Scuri M, Collarini S, Vezzoli S, Mariotti F, Muraro A, Acerbi D

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2001-2014

Published Date: 7 July 2017

Active smoking and COPD phenotype: distribution and impact on prognostic factors

Riesco JA, Alcázar B, Trigueros JA, Campuzano A, Pérez J, Lorenzo JL

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1989-1999

Published Date: 6 July 2017

Fluticasone propionate/formoterol for COPD management: a randomized controlled trial

Papi A, Dokic D, Tzimas W, Mészáros I, Olech-Cudzik A, Koroknai Z, McAulay K, Mersmann S, Dalvi PS, Overend T

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1961-1971

Published Date: 5 July 2017

Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting

Stephenson JJ, Wertz D, Gu T, Patel J, Dalal AA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1947-1959

Published Date: 4 July 2017

Characterization of throat microbial flora in smokers with or without COPD

Diao W, Shen N, Du Y, Qian K, He B

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1933-1946

Published Date: 4 July 2017

Prevalence and associated factors of COPD among Aboriginal peoples in Canada: a cross-sectional study

Bird Y, Moraros J, Mahmood R, Esmaeelzadeh S, Kyaw Soe NM

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1915-1922

Published Date: 30 June 2017

Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle

Shaikh N, Johnson M, Hall DA, Chung KF, Riley JH, Worsley S, Bhavsar PK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1903-1913

Published Date: 30 June 2017

Interfaces and ventilator settings for long-term noninvasive ventilation in COPD patients

Callegari J, Magnet FS, Taubner S, Berger M, Schwarz SB, Windisch W, Storre JH

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1883-1889

Published Date: 28 June 2017

Double bronchodilation in chronic obstructive pulmonary disease: a crude analysis from a systematic review

Lopez-Campos JL, Calero-Acuña C, Márquez-Martín E, Quintana Gallego E, Carrasco-Hernández L, Abad Arranz M, Ortega Ruiz F

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1867-1876

Published Date: 23 June 2017

Th17 profile in COPD exacerbations

Ponce-Gallegos MA, Ramírez-Venegas A, Falfán-Valencia R

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1857-1865

Published Date: 22 June 2017

Anti-p-benzoquinone antibody level as a prospective biomarker to identify smokers at risk for COPD

Banerjee S, Bhattacharyya P, Mitra S, Kundu S, Panda S, Chatterjee IB

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1847-1856

Published Date: 21 June 2017

Hospital admissions and mortality in patients with COPD exacerbations and vertebral body compression fractures

Pascual-Guardia S, Badenes-Bonet D, Martin-Ontiyuelo C, Zuccarino F, Marín-Corral J, Rodríguez A, Barreiro E, Gea J

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1837-1845

Published Date: 21 June 2017

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD

Zysman M, Deslee G, Caillaud D, Chanez P, Escamilla R, Court-Fortune I, Nesme-Meyer P, Perez T, Paillasseur JL, Pinet C, Jebrak G, Roche N, Burgel PR

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1819-1824

Published Date: 20 June 2017

Prevalence and characteristics of asthma–COPD overlap syndrome identified by a stepwise approach

Inoue H, Nagase T, Morita S, Yoshida A, Jinnai T, Ichinose M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1803-1810

Published Date: 20 June 2017

Dysregulation of microRNA-214 and PTEN contributes to the pathogenesis of hypoxic pulmonary hypertension

Liu H, Yin T, Yan W, Si R, Wang B, Chen M, Li F, Wang Q, Tao L

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1781-1791

Published Date: 19 June 2017

Serum levels of IGFBP7 are elevated during acute exacerbation in COPD patients

Ruan W, Wu M, Shi L, Li F, Dong L, Qiu Y, Wu X, Ying K

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1775-1780

Published Date: 19 June 2017

Palliative care and prognosis in COPD: a systematic review with a validation cohort

Almagro P, Yun S, Sangil A, Rodríguez-Carballeira M, Marine M, Landete P, Soler-Cataluña JJ, Soriano JB, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1721-1729

Published Date: 9 June 2017

Pulmonary rehabilitation in COPD – available resources and utilization in Swedish primary and secondary care

Sundh J, Lindgren H, Hasselgren M, Montgomery S, Janson C, Ställberg B, Lisspers K

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1695-1704

Published Date: 8 June 2017

Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide

Blanco I, Bueno P, Diego I, Pérez-Holanda S, Lara B, Casas-Maldonado F, Esquinas C, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1683-1694

Published Date: 8 June 2017

Development of a training program to support health care professionals to deliver the SPACE for COPD self-management program

Blackmore C, Johnson-Warrington VL, Williams JEA, Apps LD, Young HML, Bourne CLA, Singh SJ

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1669-1681

Published Date: 7 June 2017

Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care

Rothnie KJ, Chandan JS, Goss HG, Müllerová H, Quint JK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1663-1668

Published Date: 7 June 2017

An analysis of the economic and patient outcome impact of an integrated COPD service in east London

Garner A, Hodson M, Ketsetzis G, Pulle L, Yorke J, Bhowmik A

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1653-1662

Published Date: 6 June 2017

Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens

Kawamatawong T, Apiwattanaporn A, Siricharoonwong W

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1625-1630

Published Date: 31 May 2017

Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease

Chubachi S, Takahashi S, Tsutsumi A, Kameyama N, Sasaki M, Naoki K, Soejima K, Nakamura H, Asano K, Betsuyaku T

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1613-1624

Published Date: 30 May 2017

Development of a nomogram for predicting in-hospital mortality of patients with exacerbation of chronic obstructive pulmonary disease

Sakamoto Y, Yamauchi Y, Yasunaga H, Takeshima H, Hasegawa W, Jo T, Sasabuchi Y, Matsui H, Fushimi K, Nagase T

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1605-1611

Published Date: 29 May 2017

Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study

Kim CJ, Yoon HK, Park MJ, Yoo KH, Jung KS, Park JW, Lim SY, Shim JJ, Lee YC, Kim YS, Oh YM, Kim S, Yoo CG

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1589-1596

Published Date: 29 May 2017

Delayed but successful response to noninvasive ventilation in COPD patients with acute hypercapnic respiratory failure

Lemyze M, Bury Q, Guiot A, Jonard M, Mohammad U, Van Grunderbeeck N, Gasan G, Thevenin D, Mallat J

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1539-1547

Published Date: 25 May 2017

Proteasome activity related with the daily physical activity of COPD patients

Lee KY, Chen TT, Chiang LL, Chuang HC, Feng PH, Liu WT, Chen KY, Ho SC

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1519-1525

Published Date: 22 May 2017

Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK

Maddi S, Kolsum U, Jackson S, Barraclough R, Maschera B, Simpson KD, Pascal TG, Durviaux S, Hessel EM, Singh D

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1507-1518

Published Date: 22 May 2017

Clinical characteristics of COPD patients with tidal expiratory flow limitation

Dean J, Kolsum U, Hitchen P, Gupta V, Singh D

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1503-1506

Published Date: 22 May 2017

The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017

Menezes AM, Wehrmeister FC, Perez-Padilla R, Viana KP, Soares C, Müllerova H, Valdivia G, Jardim JR, Montes de Oca M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1491-1501

Published Date: 18 May 2017

Development of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama study

Samukawa T, Matsumoto K, Tsukuya G, Koriyama C, Fukuyama S, Uchida A, Mizuno K, Miyahara H, Kiyohara Y, Ninomiya T, Inoue H

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1469-1481

Published Date: 15 May 2017

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials

Eriksson G, Calverley PM, Jenkins CR, Anzueto AR, Make BJ, Lindberg M, Fagerås M, Postma DS

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1457-1468

Published Date: 15 May 2017

Two CHRN susceptibility variants for COPD are genetic determinants of emphysema and chest computed tomography manifestations in Chinese patients

Zhao Z, Jiang C, Zhao D, Li Y, Liang CX, Liu W, Wei S, Zhou Y, Zhao Z, Ran P

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1447-1455

Published Date: 15 May 2017

Pulmonary artery to aorta ratio is associated with cardiac structure and functional changes in mild-to-moderate COPD

Cuttica MJ, Bhatt SP, Rosenberg SR, Beussink L, Shah SJ, Smith LJ, Dransfield MT, Kalhan R

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1439-1446

Published Date: 12 May 2017

Bronchiectasis in COPD patients: more than a comorbidity?

Martinez-Garcia MA, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1401-1411

Published Date: 11 May 2017

The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece

Souliotis K, Kousoulakou H, Hillas G, Tzanakis N, Toumbis M, Vassilakopoulos T

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1395-1400

Published Date: 10 May 2017

Genetic polymorphism and chronic obstructive pulmonary disease

Yuan CH, Chang D, Lu GM, Deng XW

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1385-1393

Published Date: 10 May 2017

Bronchiectasis and increased risk of ischemic stroke: a nationwide population-based cohort study

Chen YF, Lin HH, Lin CS, Turbat B, Wang KA, Chung WS

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1375-1383

Published Date: 10 May 2017

The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD

Anzueto AR, Vogelmeier CF, Kostikas K, Mezzi K, Fucile S, Bader G, Shen S, Banerji D, Fogel R

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1325-1337

Published Date: 4 May 2017

Hydrogen coadministration slows the development of COPD-like lung disease in a cigarette smoke-induced rat model

Liu X, Ma C, Wang X, Wang W, Li Z, Wang X, Wang P, Sun W, Xue B

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1309-1324

Published Date: 2 May 2017

Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review

Edgar RG, Patel M, Bayliss S, Crossley D, Sapey E, Turner AM

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1295-1308

Published Date: 2 May 2017

Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD

Gao J, Zhang M, Zhou LQ, Yang X, Wu HG, Zhang JF, Wu F

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1287-1293

Published Date: 27 April 2017

Home noninvasive positive pressure ventilation with built-in software in stable hypercapnic COPD: a short-term prospective, multicenter, randomized, controlled trial

Zhou L, Li X, Guan L, Chen J, Guo B, Wu W, Huo Y, Zhou Z, Liang Z, Zhou Y, Tan J, Chen X, Song Y, Chen R

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1279-1286

Published Date: 27 April 2017

Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters

Zou Y, Chen X, Liu J, Zhou DB, Kuang X, Xiao J, Yu Q, Lu XX, Li W, Xie B, Chen Q

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1247-1254

Published Date: 24 April 2017

COPD is a clear risk factor for increased use of resources and adverse outcomes in patients undergoing intervention for colorectal cancer: a nationwide study in Spain

Baré M, Montón C, Mora L, Redondo M, Pont M, Escobar A, Sarasqueta C, Fernández de Larrea N, Briones E, Quintana JM

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1233-1241

Published Date: 21 April 2017

Home monitoring of breathing rate in people with chronic obstructive pulmonary disease: observational study of feasibility, acceptability, and change after exacerbation

Rubio N, Parker RA, Drost EM, Pinnock H, Weir CJ, Hanley J, Mantoani LC, McKinstry B, Rabinovich RA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1221-1231

Published Date: 20 April 2017

The association between risk of airflow limitation and serum uric acid measured at medical health check-ups

Fukuhara A, Saito J, Sato S, Saito K, Fukuhara N, Tanino Y, Wang X, Rinno K, Suzuki H, Munakata M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1213-1219

Published Date: 19 April 2017

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD

Thulborn SJ, Dilpazir M, Haldar K, Mistry V, Brightling CE, Barer MR, Bafadhel M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1199-1205

Published Date: 18 April 2017

Frailty syndrome in ambulatory patients with COPD

Limpawattana P, Putraveephong S, Inthasuwan P, Boonsawat W, Theerakulpisut D, Chindaprasirt J

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1193-1198

Published Date: 18 April 2017

Characterization of sputum biomarkers for asthma–COPD overlap syndrome [Erratum]

Gao J, Iwamoto H, Koskela J, Alenius H, Hattori N, Kohno N, Laitinen T, Mazur W, Pulkkinen V

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1191-1192

Published Date: 18 April 2017

Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction

Adrish M, Nannaka VB, Cano EJ, Bajantri B, Diaz-Fuentes G

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1183-1189

Published Date: 13 April 2017

Self-reported daily walking time in COPD: relationship with relevant clinical and functional characteristics

Ramon MA, Esquinas C, Barrecheguren M, Pleguezuelos E, Molina J, Quintano JA, Roman-Rodríguez M, Naberan K, Llor C, Roncero C, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1173-1181

Published Date: 13 April 2017

Identification of subtypes in subjects with mild-to-moderate airflow limitation and its clinical and socioeconomic implications

Lee JH, Rhee CK, Kim K, Kim J, Kim SH, Yoo K, Kim WJ, Park YB, Park HY, Jung KS

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1135-1144

Published Date: 12 April 2017

Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease

Oda N, Miyahara N, Ichikawa H, Tanimoto Y, Kajimoto K, Sakugawa M, Kawai H, Taniguchi A, Morichika D, Tanimoto M, Kanehiro A, Kiura K

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1119-1124

Published Date: 10 April 2017

Accelerometer- versus questionnaire-based assessment of physical activity and their changes over time in patients with COPD

Sievi NA, Brack T, Brutsche MH, Frey M, Irani S, Leuppi JD, Thurnheer R, Kohler M, Clarenbach CF

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1113-1118

Published Date: 10 April 2017

Peripheral leukocyte microRNAs as novel biomarkers for COPD

Wang R, Xu J, Liu H, Zhao Z

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1101-1112

Published Date: 6 April 2017

Burden of asthma, dyspnea, and chronic cough in South Asia

Bishwajit G, Tang S, Yaya S, Feng Z

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1093-1099

Published Date: 6 April 2017

Pulmonary rehabilitation for COPD improves exercise time rather than exercise tolerance: effects and mechanisms

Miki K, Maekura R, Kitada S, Miki M, Yoshimura K, Yamamoto H, Kawabe T, Kagawa H, Oshitani Y, Satomi A, Nishida K, Sawa N, Inoue K

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1061-1070

Published Date: 3 April 2017

Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study

Dres M, Hausfater P, Foissac F, Bernard M, Joly LM, Sebbane M, Philippon AL, Gil-Jardiné C, Schmidt J, Maignan M, Treluyer JM, Roche N

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1047-1056

Published Date: 31 March 2017

COPD is commonly underdiagnosed in patients with lung cancer: results from the RECOIL study (retrospective study of COPD infradiagnosis in lung cancer)

Parrón Collar D, Pazos Guerra M, Rodriguez P, Gotera C, Mahíllo-Fernández I, Peces-Barba G, Seijo LM

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1033-1038

Published Date: 30 March 2017

Barriers and enablers of physical activity engagement for patients with COPD in primary care

Kosteli MC, Heneghan NR, Roskell C, Williams SE, Adab P, Dickens AP, Enocson A, Fitzmaurice DA, Jolly K, Jordan R, Greenfield S, Cumming J

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1019-1031

Published Date: 28 March 2017

Factors contributing to high-cost hospital care for patients with COPD

Mulpuru S, McKay J, Ronksley PE, Thavorn K, Kobewka DM, Forster AJ

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:989-995

Published Date: 24 March 2017

Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function

Waschki B, Watz H, Holz O, Magnussen H, Olejnicka B, Welte T, Rabe KF, Janciauskiene S

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:981-987

Published Date: 22 March 2017

Measures of bronchodilator response of FEV1, FVC and SVC in a Swedish general population sample aged 50–64 years, the SCAPIS Pilot Study

Torén K, Bake B, Olin A-C, Engström G, Blomberg A, Vikgren J, Hedner J, Brandberg J, Persson HL, Sköld CM, Rosengren A, Bergström G, Janson C

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:973-980

Published Date: 22 March 2017

Impact of a COPD comprehensive case management program on hospital length of stay and readmission rates

Alshabanat A, Otterstatter MC, Sin DD, Road J, Rempel C, Burns J, van Eeden SF, FitzGerald JM

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:961-971

Published Date: 21 March 2017

Intratracheal transplantation of endothelial progenitor cells attenuates smoking-induced COPD in mice

Shi Z, Chen Y, Cao J, Zeng H, Yang Y, Chen P, Luo H, Peng H, Cai S, Guan C

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:947-960

Published Date: 20 March 2017

Current asthma contributes as much as smoking to chronic bronchitis in middle age: a prospective population-based study [Corrigendum]

Dharmage SC, Perret JL, Burgess JA, Lodge CJ, Johns DP, Thomas PS, Giles GG, Hopper JL, Abramson MJ, Walters EH, Matheson MC

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:945-946

Published Date: 20 March 2017

Greater dyspnea is associated with lower health-related quality of life among European patients with COPD

Gruenberger JB, Vietri J, Keininger DL, Mahler DA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:937-944

Published Date: 20 March 2017

Association between RTEL1 gene polymorphisms and COPD susceptibility in a Chinese Han population

Ding YP, Xu HP, Yao JJ, Xu DC, He P, Yi SY, Li QN, Liu YS, Wu CB, Tian ZJ

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:931-936

Published Date: 17 March 2017

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis

Rodrigo GJ, Price D, Anzueto A, Singh D, Altman P, Bader G, Patalano F, Fogel R, Kostikas K

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:907-922

Published Date: 17 March 2017

Evidence of eosinophil extracellular trap cell death in COPD: does it represent the trigger that switches on the disease?

Uribe Echevarría L, Leimgruber C, García González J, Nevado A, Álvarez R, García LN, Quintar AA, Maldonado CA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:885-896

Published Date: 14 March 2017

Positive correlation of airway resistance and serum asymmetric dimethylarginine level in COPD patients with systemic markers of low-grade inflammation

Tajti G, Gesztelyi R, Pak K, Papp C, Keki S, Szilasi ME, Mikaczo A, Fodor A, Szilasi M, Zsuga J

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:873-884

Published Date: 14 March 2017

Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey [Corrigendum]

Müllerová H, Landis SH, Aisanov Z, Davis KJ, Ichinose M, Mannino DM, Maskell J, Menezes AM, van der Molen T, Oh YM, Tabberer M, Han MK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:859-860

Published Date: 15 March 2017

Is cardiac autonomic modulation during upper limb isometric contraction and Valsalva maneuver impaired in COPD patients?

Goulart CL, Cabiddu R, Schneiders PB, Antunes San Martin E, Trimer R, Borghi-Silva A, da Silva ALG

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:849-857

Published Date: 13 March 2017

Colds as predictors of the onset and severity of COPD exacerbations

Johnston NW, Olsson M, Edsbäcker S, Gerhardsson de Verdier M, Gustafson P, McCrae C, Coyle PV, McIvor RA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:839-848

Published Date: 10 March 2017

Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?

Carleo A, Chorostowska-Wynimko J, Koeck T, Mischak H, Czajkowska-Malinowska M, Rozy A, Welte T, Janciauskiene S

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:829-837

Published Date: 8 March 2017

Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians

Yan X, Song Y, Shen C, Xu WB, Chen L, Zhang J, Liu H, Huang M, Lai G, Qian G, Wang J, Ye X, Zheng J, Bai C

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:803-812

Published Date: 22 March 2017

Inhaled treatment of COPD: a Delphi consensus statement

Ninane V, Corhay JL, Germonpré P, Janssens W, Joos GF, Liistro G, Vincken W, Gurdain S, Vanvlasselaer E, Lehouck A

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:793-801

Published Date: 6 March 2017

Seasonal variability in clinical care of COPD outpatients: results from the Andalusian COPD audit

López-Campos JL, Abad Arranz M, Calero-Acuña C, Romero-Valero F, Ayerbe-García R, Hidalgo-Molina A, Aguilar-Pérez-Grovas RI, García-Gil F, Casas-Maldonado F, Caballero-Ballesteros L, Sánchez-Palop M, Pérez-Tejero D, Segado Soriano A, Calvo-Bonachera J, Hernández-Sierra B, Doménech A, Arroyo-Varela M, González-Vargas F, Cruz-Rueda JJ

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:785-792

Published Date: 3 March 2017

Decreased levels of irisin, a skeletal muscle cell-derived myokine, are related to emphysema associated with chronic obstructive pulmonary disease

Sugiyama Y, Asai K, Yamada K, Kureya Y, Ijiri N, Watanabe T, Kanazawa H, Hirata K

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:765-772

Published Date: 2 March 2017

Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study

Kerwin EM, Kalberg CJ, Galkin DV, Zhu C, Church A, Riley JH, Fahy WA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:745-755

Published Date: 24 February 2017

Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population

Schwab P, Dhamane AD, Hopson SD, Moretz C, Annavarapu S, Burslem K, Renda A, Kaila S

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:735-744

Published Date: 23 February 2017

Occupational COPD and job exposure matrices: a systematic review and meta-analysis

Sadhra S, Kurmi OP, Sadhra SS, Lam KB, Ayres JG

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:725-734

Published Date: 22 February 2017

Effect of simvastatin on MMPs and TIMPs in cigarette smoke-induced rat COPD model

Sun J, Bao J, Shi Y, Zhang B, Yuan L, Li J, Zhang L, Sun M, Zhang L, Sun W

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:717-724

Published Date: 22 February 2017

Repression of Toll-like receptor-4 by microRNA-149-3p is associated with smoking-related COPD

Shen W, Liu J, Zhao G, Fan M, Song G, Zhang Y, Weng Z, Zhang Y

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:705-715

Published Date: 22 February 2017

Heterogeneity of asthma–COPD overlap syndrome

Joo H, Han D, Lee JH, Rhee CK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:697-703

Published Date: 22 February 2017

The immediate effect of soft tissue manual therapy intervention on lung function in severe chronic obstructive pulmonary disease

Cruz-Montecinos C, Godoy-Olave D, Contreras-Briceño FA, Gutiérrez P, Torres-Castro R, Miret-Venegas L, Engel RM

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:691-696

Published Date: 21 February 2017

COPD symptom burden: impact on health care resource utilization, and work and activity impairment

Ding B, Small M, Bergström G, Holmgren U

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:677-689

Published Date: 21 February 2017

Sarcopenia correlates with systemic inflammation in COPD

Byun MK, Cho EN, Chang J, Ahn CM, Kim HJ

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:669-675

Published Date: 20 February 2017

Natural course of early COPD

Rhee CK, Kim K, Yoon HK, Kim JA, Kim SH, Lee SH, Park YB, Jung KS, Yoo KH, Hwang YI

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:663-668

Published Date: 20 February 2017

Is exposure to biomass smoke really associated with COPD?

Das V, Nitin V, Salvi S, Kodgule R

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:651-653

Published Date: 17 February 2017

MiR-344b-1-3p targets TLR2 and negatively regulates TLR2 signaling pathway

Xu H, Wu Y, Li L, Yuan W, Zhang D, Yan Q, Guo Z, Huang W

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:627-638

Published Date: 14 February 2017

Can we predict the prognosis of COPD with a routine blood test?

Xiong W, Xu M, Zhao YF, Wu XL, Pudasaini B, Liu JM

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:615-625

Published Date: 13 February 2017

A Belgian survey on the diagnosis of asthma–COPD overlap syndrome

Cataldo D, Corhay JL, Derom E, Louis R, Marchand E, Michils A, Ninane V, Peché R, Pilette C, Vincken W, Janssens W

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:601-613

Published Date: 13 February 2017

Reduced nuclear translocation of serum response factor is associated with skeletal muscle atrophy in a cigarette smoke-induced mouse model of COPD

Ma R, Gong XF, Jiang H, Lin CY, Chen YQ, Xu XM, Zhang CT, Wang J, Lu WJ, Zhong NS

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:581-587

Published Date: 20 February 2017

Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update

Blanco I, Bueno P, Diego I, Pérez-Holanda S, Casas-Maldonado F, Esquinas C, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:561-569

Published Date: 13 February 2017

Longitudinal changes in structural abnormalities using MDCT in COPD: do the CT measurements of airway wall thickness and small pulmonary vessels change in parallel with emphysematous progression?

Takayanagi S, Kawata N, Tada Y, Ikari J, Matsuura Y, Matsuoka S, Matsushita S, Yanagawa N, Kasahara Y, Tatsumi K

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:551-560

Published Date: 13 February 2017

A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey

Ding B, DiBonaventura M, Karlsson N, Bergström G, Holmgren U

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:529-539

Published Date: 7 February 2017

Longitudinal changes in lung hyperinflation in COPD

Park J, Lee CH, Lee YJ, Park JS, Cho YJ, Lee JH, Lee CT, Yoon HI

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:501-508

Published Date: 3 February 2017

“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD

Vogelmeier C, Worth H, Buhl R, Criée C, Lossi NS, Mailänder C, Kardos P

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:487-494

Published Date: 1 February 2017

Determining prognosis in acute exacerbation of COPD

Flattet Y, Garin N, Serratrice J, Perrier A, Stirnemann J, Carballo S

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:467-475

Published Date: 31 January 2017

The pharmacological cost of COPD during Greek economic crisis

Stafyla E, Kerenidi T, Gerogianni I, Geitona M, Daniil Z, Gourgoulianis KI

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:461-466

Published Date: 31 January 2017

Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy

Martin M, Almeras N, Després JP, Coxson HO, Washko GR, Vivodtzev I, Wouters EFM, Rutten E, Williams MC, Murchison JT, MacNee W, Sin DD, Maltais F

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:451-460

Published Date: 31 January 2017

Lung and kidney: a dangerous liaison? A population-based cohort study in COPD patients in Italy

Fedeli U, De Giorgi A, Gennaro N, Ferroni E, Gallerani M, Mikhailidis DP, Manfredini R, Fabbian F

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:443-450

Published Date: 27 January 2017

Risk factors for FEV1 decline in mild COPD and high-risk populations

Chen SJ, Wang CH, Li B, Shi GC, Li HP, Zhang J, Gu YT, Zhou J, Song YL, Bai CX

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:435-442

Published Date: 27 January 2017

Patterns and characterization of COPD exacerbations using real-time data collection

Ejiofor SI, Stolk J, Fernandez P, Stockley RA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:427-434

Published Date: 25 January 2017

Clinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL study

Calle Rubio M, Alcazar-Navarrete B, Soriano JB, Soler-Cataluña JJ, Rodriguez González-Moro JM, Fuentes Ferrer ME, Lopez-Campos JL

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:417-426

Published Date: 25 January 2017

Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary disease

Kim SW, Rhee CK, Kim KU, Lee SH, Hwang HG, Kim YI, Kim DK, Lee SD, Oh YM, Yoon HK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:395-402

Published Date: 21 January 2017

Coil therapy for patients with severe emphysema and bilateral incomplete fissures – effectiveness and complications after 1-year follow-up: a single-center experience

Kontogianni K, Gerovasili V, Gompelmann D, Schuhmann M, Hoffmann H, Heussel CP, Herth FJF, Eberhardt R

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:383-394

Published Date: 23 January 2017

Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis

Donohue JF, Betts KA, Du EX, Altman P, Goyal P, Keininger DL, Gruenberger JB, Signorovitch JE

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:367-381

Published Date: 19 January 2017

A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD

Bhatt SP, Dransfield MT, Cockcroft JR, Wang-Jairaj J, Midwinter DA, Rubin DB, Scott-Wilson CA, Crim C

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:351-365

Published Date: 19 January 2017

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study

Wedzicha JA, Zhong N, Ichinose M, Humphries M, Fogel R, Thach C, Patalano F, Banerji D

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:339-349

Published Date: 19 January 2017

Prevalence of swallowing dysfunction screened in Swedish cohort of COPD patients

Gonzalez Lindh M, Blom Johansson M, Jennische M, Koyi H

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:331-337

Published Date: 17 January 2017

The role of tuberculosis in COPD

Yakar HI, Gunen H, Pehlivan E, Aydogan S

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:323-329

Published Date: 17 January 2017

Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records

Williams NP, Coombs NA, Johnson MJ, Josephs LK, Rigge LA, Staples KJ, Thomas M, Wilkinson TMA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:313-322

Published Date: 17 January 2017

The view of pulmonologists on palliative care for patients with COPD: a survey study

Duenk RG, Verhagen C, Dekhuijzen PNR, Vissers KCP, Engels Y, Heijdra Y

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:299-311

Published Date: 17 January 2017

Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care

Bathoorn E, Groenhof F, Hendrix R, van der Molen T, Sinha B, Kerstjens HA, Friedrich AW, Kocks JW

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:285-290

Published Date: 13 January 2017

Predicting high risk of exacerbations in bronchiectasis: the E-FACED score

Martinez-Garcia MA, Athanazio RA, Girón R, Máiz-Carro L, de la Rosa D, Olveira C, de Gracia J, Vendrell M, Prados-Sánchez C, Gramblicka G, Corso Pereira M, Lundgren FL, Fernandes de Figuereido M, Arancibia F, Rached SZ

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:275-284

Published Date: 18 January 2017

Birmingham COPD Cohort: a cross-sectional analysis of the factors associated with the likelihood of being in paid employment among people with COPD

Rai KK, Jordan RE, Siebert WS, Sadhra SS, Fitzmaurice DA, Sitch AJ, Ayres JG, Adab P

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:233-242

Published Date: 11 January 2017

Global scientific collaboration in COPD research

Su YB, Long C, Yu Q, Zhang J, Wu D, Duan ZG

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:215-225

Published Date: 6 January 2017

Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization

Dilektasli AG, Demirdogen Cetinoglu E, Uzaslan E, Budak F, Coskun F, Ursavas A, Ercan I, Ege E

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:199-208

Published Date: 5 January 2017

Flexible bronchoscopy with moderate sedation in COPD: a case–control study

Grendelmeier P, Tamm M, Jahn K, Pflimlin E, Stolz D

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:177-187

Published Date: 4 January 2017

Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients

Dhamane AD, Schwab P, Hopson S, Moretz C, Annavarapu S, Burslem K, Renda A, Kaila S

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:115-122

Published Date: 22 December 2016

Psychometric properties of the Physical Activity Scale for the Elderly in Chinese patients with COPD

Tao YX, Wang L, Dong XY, Zheng H, Zheng YS, Tang XY, Zhao Y, Zhang Q

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:105-114

Published Date: 22 December 2016

Gender differences in partners of patients with COPD and their perceptions about the patients

Nakken N, Janssen DJA, van Vliet M, de Vries GJ, Clappers-Gielen GAL, Michels AJ, Muris JWM, Vercoulen JH, Wouters EFM, Spruit MA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:95-104

Published Date: 23 December 2016

Network pharmacology-based identification of key pharmacological pathways of Yin–Huang–Qing–Fei capsule acting on chronic bronchitis

Yu GH, Zhang YQ, Ren WQ, Dong L, Li JF, Geng Y, Zhang Y, Li DF, Xu HY, Yang HJ

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:85-94

Published Date: 22 December 2016

Initiation of triple therapy maintenance treatment among patients with COPD in the US

Simeone JC, Luthra R, Kaila S, Pan X, Bhagnani TD, Liu J, Wilcox TK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:73-83

Published Date: 22 December 2016

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes

Bosnic-Anticevich S, Chrystyn H, Costello RW, Dolovich MB, Fletcher MJ, Lavorini F, Rodríguez-Roisin R, Ryan D, Wan Yau Ming S, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:59-71

Published Date: 21 December 2016

Psychometric properties of the Anxiety Inventory for Respiratory Disease in patients with COPD in China

Dong X, Wang L, Tao Y, Suo X, Li Y, Liu F, Zhao Y, Zhang Q

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:49-58

Published Date: 20 December 2016

Gender differences in the T-cell profiles of the airways in COPD patients associated with clinical phenotypes

Forsslund H, Yang M, Mikko M, Karimi R, Nyrén S, Engvall B, Grunewald J, Merikallio H, Kaarteenaho R, Wahlström J, Wheelock ÅM, Sköld CM

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:35-48

Published Date: 20 December 2016

Trend of cost and utilization of COPD medication in Korea

Lee J, Lee JH, Kim J, Rhee CK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:27-33

Published Date: 19 December 2016

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD

Calverley PM, Eriksson G, Jenkins CR, Anzueto AR, Make BJ, Persson A, Fagerås M, Postma DS

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:13-25

Published Date: 19 December 2016

Domain-specific cognitive impairment in patients with COPD and control subjects

Cleutjens FAHM, Franssen FME, Spruit MA, Vanfleteren LEGW, Gijsen C, Dijkstra JB, Ponds RWHM, Wouters EFM, Janssen DJA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1-11

Published Date: 19 December 2016